DERMATOFIBROSARCOMA PROTUBERANS (DFSP)

Clinical trials for DERMATOFIBROSARCOMA PROTUBERANS (DFSP) explained in plain language.

Never miss a new study

Get alerted when new DERMATOFIBROSARCOMA PROTUBERANS (DFSP) trials appear

Sign up with your email to follow new studies for DERMATOFIBROSARCOMA PROTUBERANS (DFSP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for rare skin cancer? drug cocktail targets resistant DFSP

Disease control Not yet recruiting

This phase 2 trial will test whether combining two newer drugs (toripalimab and anlotinib) with standard chemotherapy can shrink tumors in people with a rare skin cancer called dermatofibrosarcoma protuberans (DFSP) that has stopped responding to the usual treatment. The study pl…

Matched conditions: DERMATOFIBROSARCOMA PROTUBERANS (DFSP)

Phase: PHASE2 • Sponsor: Yanjie Zhang, MD • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

DERMATOFIBROSARCOMA PROTUBERANS (DFSP)

Get alerted when new DERMATOFIBROSARCOMA PROTUBERANS (DFSP) trials appear

New hope for rare skin cancer? drug cocktail targets resistant DFSP